Conclusion the expressional intensity of COX-2 in ovarian cancer in combination with the half life time of CA125 might predict drug resistance in ovarian cancer.
结论COX - 2在卵巢癌中的表达强度与CA125半衰期的联合判断可以预测卵巢癌的耐药。
Conclusion the expressional intensity of COX-2 in ovarian cancer in combination with the half life time of CA125 might predict drug resistance in ovarian cancer.
结论COX - 2在卵巢癌中的表达强度与CA125半衰期的联合判断可以预测卵巢癌的耐药。
应用推荐